MIMS, SA
ent_019eed00ea56af35d92d757c08d0e393
Disclosures
2
Leak Site · 1 jurisdiction
Incidents
—
no linked incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
2
unverified actor claims
Identity resolution
- Canonical name
- MIMS, SA
- Normalized
- mims— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 8945003YFEKXGIP8R367
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- mims.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2026-04-27
mims.com zoominfo.com/c/mims-pte-ltd/354424916 MIMS is a pharmaceutical prescribing reference guide first published in the United Kingdom in 1959 by Haymarket Media Group. The platform provides comprehensive drug information — including dosages, interactions, clinical guidelines, and prescribing data — for healthcare professionals across the globe. MIMS operates internationally across Asia, Australia, and beyond, with dedicated editions for countries including Malaysia, India, Indonesia, Japan, Singapore, and many others. Its mobile app and online database are used daily by doctors and pharmacists for drug lookups, medical news, and CME articles
- GLOBALLeak Siteas victim2026-01-21
Mims.com is an online resource for medical professionals used mainly in Asia-Pacific and Middle East regions. It provides latest drug information and medical news, with a database featuring information about thousands of prescription medications. It also offers feature articles, opinion pieces and continuing medical education (CME) activities. It's extensively used by doctors, pharmacists, nurses and students.